Lung Cancer Clinical Trial

Clinical Trial Finder Lung Cancer Trials

ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial.

See Locations Near You

Summary

The purpose of this study is to evaluate the effects (good and bad) of LY231514 (ALIMTA) and Carboplatin on you and your non-small cell lung cancer.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

You have a diagnosis of non-small cell lung cancer.
You have received no prior chemotherapy.
You have at least one measurable lesion.
You have an adequate performance status.
You are at least 18 years of age.

Exclusion Criteria:

You have previously received chemotherapy for your lung cancer.
You have received radiation within the last 30 days.
You have active infection or other serious condition.
You have brain metastasis.
You have recently lost a significant amount of weight.

Study is for people with:

Lung Cancer

Phase:

Phase 2

Estimated Enrollment:

50

Study ID:

NCT00051493

Recruitment Status:

Completed

Sponsor:

Eli Lilly and Company

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You


Houston Texas, , United States

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Phase:

Phase 2

Estimated Enrollment:

50

Study ID:

NCT00051493

Recruitment Status:

Completed

Sponsor:


Eli Lilly and Company

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
Clinical Trials Can be Life-Saving for Some
When Should I Consider Clinical Trials?
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider